Indian Pharmacopoeia 2026: 10th Edition Released with 121 New Monographs

Syllabus: Health Sector Reforms and Regulation

Ministry of Health and Family Welfare

Why in news?

Union Health Minister released Indian Pharmacopoeia 2026, the 10th edition with 3,340 total monographs. India's pharmacovigilance ranking improved from 123rd (2009-14) to 8th globally in 2025.

⚛️Static Concepts

Drugs and Cosmetics Act 1940CDSCOCentral Drugs Standard Control Organization

📌

Prelims-Oriented Points

Indian Pharmacopoeia 2026 is the 10th edition; 121 new monographs added, total 3,340 monographs.
First-time inclusion of 20 blood component monographs for transfusion medicine.
India's WHO pharmacovigilance ranking: Improved from 123rd (2009-14) to 8th globally (2025).
Indian Pharmacopoeia recognized in 19 countries of the global south; part of Pharmacopoeial Discussion Group (PDG).

⚠️

Examiner's Trap: Indian Pharmacopoeia is published by Indian Pharmacopoeia Commission (IPC), not CDSCO or DCGI.

Quick Data Points

Total Monographs: 3,340

New Monographs: 121

WHO Ranking: 123rd → 8th

Global Recognition: 19 countries

Mains Value Addition

GS-2: Issues relating to development and management of Health

Drug Quality Assurance: Pharmacopoeia standards are legally enforceable, ensuring quality of medicines under National Health Programmes.
Global Integration: Harmonization with ICH standards and PDG membership positions India as a global pharmaceutical quality leader.
Pharmacovigilance: Dramatic improvement in WHO ranking reflects strengthened adverse drug reaction monitoring.

Source

Press Information Bureau (PIB)